Delphinus Medical Technologies

Website

Delphinus Medical Technologies, Inc.

8 Investors
Medical Imaging
NOVI, MI

Delphinus Medical Technologies, Inc. is a pioneering medical imaging firm based in Novi, Michigan, dedicated to transforming breast cancer screening, especially for women with dense breast tissue. The company is renowned for developing the SoftVue™ system, which utilizes advanced ultrasound technology to improve cancer detection and streamline the screening process.

Products & Team

SoftVue™ 3D Whole Breast Ultrasound Tomography System

Breast Cancer ScreeningSeed

The SoftVue™ system is an FDA-approved medical device that utilizes revolutionary circular array transducer technology to produce three-dimensional whole breast ultrasound images. The device uniquely employs sound and water for imaging, avoiding the discomfort associated with compression and the risks related to radiation exposure found in traditional mammography.

Value Proposition

SoftVue addresses the challenges faced by women with dense breast tissue in traditional screening methods, significantly reducing missed diagnoses and unnecessary follow-ups.

Pain Points

Women with dense breast tissue face increased challenges in cancer detection due to the limitations of traditional mammograms, leading to a higher risk of missed diagnoses and unnecessary medical procedures.

Non-invasive and comfortable – no compression or radiationQuick scanning – complete breast scans in just 2-3 minutesEnhanced cancer detection – identifies up to 20-25% more cancers when used with mammographyFDA approval validating its safety and efficacy
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
NOVI, MI
Primary headquarters

Funding History

Total Raised:
$27.6M
E

Debt Financing, Security Offering

Closed
March 2024
$27.6M
Raised
Progress
100%
Raised
$27.6M
Target
$27.6M
#000149253425000001